Mor C, Orefice S, Rocco F, Accinni R, Bartorelli A
Minerva Med. 1978 Feb 25;69(9):553-63.
An original technique for the direct radioimmunological measurement of plasma CEA has been prepared. Compared to the other in use, this has the advantage of a very low incidence of false positivity. 1704 patients make up the series: the percentage of positivity in 247 suffering from gastroenteric adenocarcinoma was 66.8%, in 60 with lung cancer 30%, in 243 with malignant tumours in various sites 7.4%, in 199 with chronic liver diseases 29.6% while in 598 cases of other non-neoplastic diseases it was only 2.5%. 212 patients who underwent radical surgery for gastroenteric adenocarcinoma were also followed up and the test provided early diagnosis of the clinical re-onset of the neoplastic lesion. It is considered that plasma CEA measurement represents a useful aid to the clinician althouth it cannot be employed at present to screen gastroenteric adenocarcinomas.
一种用于直接放射免疫测定血浆癌胚抗原(CEA)的原创技术已被开发出来。与其他现行方法相比,该技术具有假阳性发生率极低的优点。该系列研究涵盖了1704名患者:247例胃肠腺癌患者的阳性率为66.8%,60例肺癌患者为30%,243例各部位恶性肿瘤患者为7.4%,199例慢性肝病患者为29.6%,而598例其他非肿瘤性疾病患者仅为2.5%。对212例行胃肠腺癌根治术的患者进行了随访,该检测为肿瘤病变的临床复发提供了早期诊断。虽然目前不能用其来筛查胃肠腺癌,但血浆CEA测定被认为对临床医生有一定帮助。